Omalizumab retreatment in patients with chronic spontaneous urticaria:a systematic review of published evidence-Reference-Cited by-同舟云学术

Omalizumab retreatment in patients with chronic spontaneous urticaria:a systematic review of published evidence

Published:2020-05 Issue:03 Volume:52 Page:74
ISSN:1764-1489
Container-title:European Annals of Allergy and Clinical Immunology
language:
Short-container-title:Eur Ann Allergy Clin Immunol

Author:

Tonacci A.¹,Nettis E.²,Asero R.³,Rossi O.⁴,Tontini C.⁵,Gangemi S.⁶

Affiliation:

1. Institute of Clinical Physiology-National Research Council of Italy (IFC-CNR), Pisa, Italy

2. Department of Emergency and Organ Transplantation, School and Chair of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy

3. Allergology Clinic, Clinica San Carlo, Paderno Dugnano, Milan, Italy

4. ImmunoAllergology Unit, Careggi University Hospital of Florence, Florence, Italy

5. Allergy Unit, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy

6. School and Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

Publisher

Edra SpA

Subject

Immunology and Allergy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria;International Archives of Allergy and Immunology;2024

2. Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

3. Age and fast initial response predict omalizumab retreatment in chronic urticaria;The Journal of Allergy and Clinical Immunology: In Practice;2023-11

4. Therapeutical Targets in Allergic Inflammation;Biomedicines;2022-11-09

5. Aspirin Desensitization in NERD in the Era of Biologics: First or Last Resource?;Current Treatment Options in Allergy;2022-03-09